Small caps round-up: Air Partner, YouGov, Regency...

Aviation group Air Partner has unveiled Richard Everitt, the firm's current Senior Independent Director, as the successor of Aubrey Adams, Non-Executive Chairman of the company, with immediate effect. The firm said its was "delighted" that Everitt agreed to take over the role. Shares fell 3.5% to 275p.

YouGov, the international online market research agency, has said trading across the group during the six months to January 31st 2012 has been in line with its expectations and the board is confident of the full year outcome. Double digit organic revenue growth has been achieved in the six months. Shares rose 5.88% to 58.50p.

Monitise has announced a collaboration with Visa, in which Visa DPS will use Monitse's mobile services. The services allow financial institutions to offer their account holders the ability to monitor account history and balances, transfer funds between accounts, and receive near real time transaction alerts on their mobile devices. No details were given as to the value of the agreement. Monitise shares fell 0.72% to 34.25p

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Croma Group, the AIM-listed security services provider, has announced that its wholly owned subsidiary, Vigilant Security has won a five-year contract worth £1.15m per annum to secure the premises of a major listed London property group. "Once again our success highlights that the security service offered by our ex-military security professionals is recognised by the market as potent and attractive," the firm said. Shares climbed 28.99% to 2.23p.

Regency Mines has placed 19.1m shares at 2.1p each to raise £0.4m before expenses. The funds generated will be applied towards exploration expenditures in Papua New Guinea and Australia, as well as for general working capital requirements, the firm said. Shares fell 8.4% to 2.35p.

Oil and gas explorer Tower Resources' subsidiary Northland Capital Partners has placed over 180m new ordinary shares at 3p each raising £5.41m before expenses. The firm has also issued 15.8m new ordinary shares to YA Global Master, an investment fund, at 3.8p each, raising £0.6m. The funds will be put towards redeeming the principal and accrued interest of the loan provided by YA Global Masters to commence the Mvule-1 well, to complete the drilling of the well, and to general working capital requirements over the balance of 2012. Shares fell 10.06% to 3.58p.

Tanfield Group, a manufacturer of aerial work platforms, has said the trading for the second half of 2011 was similar to that of the first half and that the company's order book continued to grow as order intake significantly outstripped monthly shipment revenues. Equipment lead times extended as the growth rate was managed to ensure the company optimised the use of its working capital. Net cash at December 31st was £3.4m (December 2010: £3.6m). Shares gained 0.55% to 45.75p.

Pilat Media Global, the supplier of business management software to the media industry, announced that a prominent global media and entertainment company has gone live with its MediaPro airtime sales solution. The firm will eventually use MediaPro in nine regions across Europe. "This adoption of MediaPro by this high profile media and entertainment company is just the latest example of how the solution is rapidly becoming the standard for economical and efficient airtime ad sales management," Pilat said. Shares soared 22% to 30.5p.

Fusion IP, which commercialises university research, announced that Asalus Medical Instruments has raised £0.7m in its funding round, following a successful pre-clinical study of its lead product, known as Innervision. The funds will be used to commence Innervision's 'first-in-man' clinical study and begin the process of scaling up the technology, prior to its expected launch in 2013. Shares rose 10.43% to 63.50p.

NR